Some of the best-selling HIV medications in the world have been linked to a host of serious side effects ranging from kidney damage and kidney failure to bone density loss and bone fractures. Truvada, Atripla, Viread, Stribild and Complera are all HIV medications containing the antiretroviral drug tenofovir disoproxil fumarate (TDF), and these medications, manufactured by Gilead Sciences, have been tied to devastating bone and kidney injuries in users. In light of the potential for TDF medications to cause serious kidney and bone problems, HIV patients taking TDF-based drugs are now filing lawsuits against Gilead, alleging that the company could have prevented their injuries had the drug company not waited to introduce tenofovir alafenamide fumarate (TAF), a less toxic version of the blockbuster HIV drug that was allegedly tested in clinical trials more than a decade before its eventual release in 2015. If you believe you have been adversely affected by a TDF-based HIV drug like Truvada, Atripla, Viread, Stribild or Complera, contact our consumer advocates at Consumer Justice Foundation for help. We may be able to put you in touch with a product liability lawyer who can help you determine whether you may be eligible to file a tenofovir injury lawsuit against Gilead.
Possible side effects of TDF-based antiretroviral drugs include kidney disease, bone fractures, bone density loss and other serious side effects in individuals with HIV.Some of the best-selling HIV medications in the world have been linked to a host of serious side effects ranging from kidney damage and kidney failure to bone density loss and bone fractures. Truvada, Atripla, Viread, Stribild and Complera are all HIV medications containing the antiretroviral drug tenofovir disoproxil fumarate (TDF), and these medications, manufactured by Gilead Sciences, have been tied to devastating bone and kidney injuries in users. In light of the potential for TDF medications to cause serious kidney and bone problems, HIV patients taking TDF-based drugs are now filing lawsuits against Gilead, alleging that the company could have prevented their injuries had the drug company not waited to introduce tenofovir alafenamide fumarate (TAF), a less toxic version of the blockbuster HIV drug that was allegedly tested in clinical trials more than a decade before its eventual release in 2015. If you believe you have been adversely affected by a TDF-based HIV drug like Truvada, Atripla, Viread, Stribild or Complera, contact our consumer advocates at Consumer Justice Foundation for help. We may be able to put you in touch with a product liability lawyer who can help you determine whether you may be eligible to file a tenofovir injury lawsuit against Gilead.